03 November 2011
Engineers Australia Victorian Division recognizes Invetech and Organovo for 3D bioprinter Excellence in Engineering
Invetech, an innovator in new product development and manufacturing for the biomedical, industrial and consumer markets, has been recognized by the Victoria Division of Engineers Australia with the 2011 Engineering Excellence Award for Research & Development/Innovation. The award recognises and showcases engineering expertise from Invetech and Organovo in the development of the world's first commercial 3D bio-printer.

Keith Murphy, CEO of Organovo, based in San Diego, said the bioprinter represented a breakthrough because for the first time a flexible technology platform exists for organizations working on tissue construction and organ replacement.
"Scientists and engineers can use the 3D bio printers to enable placing cells of almost any type into a desired pattern in 3D," said Murphy. "Researchers can place liver cells on a preformed scaffold, support kidney cells with a co-printed scaffold, or form adjacent layers of epithelial and stromal soft tissue that grow into a mature tooth. Ultimately the idea would be for surgeons to have tissue on demand for various uses, and the best way to do that is get a number of 3D bio-printers in the hands of researchers throughout the U.S."
The 3D bio-printers include an intuitive software interface that allows engineers to build a model of the tissue construct before the printer commences the physical constructions of the organs cell-by-cell using automated, laser-calibrated print heads.
Organovo selected Invetech as their technology development partner. "We selected Invetech because of their capabilities for sophisticated engineering and automation, cultural fit as a long term partner and their consideration towards protecting Organovo's bioprinting IP and maximizing our commercial return on the program. They have good processes for product development and project management, and it was apparent that project execution would be handled very well. Invetech really offered the best overall package." said Mr. Murphy.
Further Press Information
Roger Langsdon, Phone: +613 9211 7782, Fax: +613 9211 7703. E-mail media@invetech.com.au.
More News
-
16 May 2012
New Technologies in Cell Therapy Manufacturing: Invetech presents at the 18th Annual ISCT Meeting
-
13 May 2012
Manufacturing Towards A Global Scale: Invetech at the World Stem Cells & Regenerative Medicine Congress 2012
-
30 April 2012
BioProcess International: Small-Batch-Size Production: Addressing the Commercial Challenge by David James
-
15 February 2012
IVD Technology: Knowledge and Experience Diversity for IVD Innovation by Invetech's Jari Palander
-
13 February 2012
Invetech's Bill Hill to speak at Product Innovation 2012: Differentiate to Dominate
-
17 January 2012
David James speaks on Cell Therapies for Cardiovascular Diseases
-
13 January 2012
Developing the World's First 3D Bioprinter: Invetech addresses the BioMelbourne Network
-
21 December 2011
FORBES declare the Coca-Cola Freestyle® Coolest Product of the Decade
-
21 December 2011
Invetech and Organovo Win Top Engineering Innovation Honour for the 3D Bioprinter
-
05 December 2011
Invetech to Present at the First Annual SLAS Conference and Exhibition
-
30 November 2011
Invetech to Present at Phacilitate's 8th Annual Cell & Gene Therapy Forum in Washington
-
03 November 2011
Engineers Australia Victorian Division recognises Invetech and Organovo for 3D bioprinter Excellence in Engineering